Dow Down 1.40% Nasdaq Down 1.59%

Gilead Sciences Inc. (GILD)

-NasdaqGS
105.59 Down 0.86(0.81%) 4:00PM EDT
|After Hours : 105.70 Up 0.11 (0.10%) 7:57PM EDT
Prev Close:106.45
Open:106.99
Bid:105.45 x 1000
Ask:106.00 x 300
1y Target Est:114.33
Beta:0.95
Earnings Date:Oct 28 - Oct 31 (Est.)
Day's Range:105.19 - 107.59
52wk Range:58.81 - 110.64
Volume:11,659,388
Avg Vol (3m):13,655,300
Market Cap:159.62B
P/E (ttm):23.92
EPS (ttm):4.41
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GILDDown 0.81%159.62B
GSKDown 0.15%110.25B
PFEDown 1.42%184.84B
RHHBYDown 0.68%249.64B

Key Statistics

Forward P/E (1 yr):11.09
P/S (ttm):9.23
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :8.04
Quarterly EPS Est (Sep-14) :1.92
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):0.54

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines for the treatment of life threatening diseases in North America, South America, Europe, and the Asia-Pacific. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback